Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrol ...
Families file wrongful death lawsuit against Camp Mystic after six young girls died in Guadalupe River flooding, alleging ...
Despite positive fundamentals, Rubrik's current valuation leaves limited margin of safety, given industry competition and ...
Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrol ...
Spokane Police and the City Council have agreed after public outcry to scrap the purchase of two portable high-range speakers ...
It's "hard to pinpoint the exact source" of the contamination at the six failing Greenwich sites, Save the Sound said.
Understand earnings calls: structure, Q&A, management tone, and key metrics investors track for performance, guidance, and ...
There are gifts, and then there are gifts, the ones inventive enough to surprise and delight the recipient. Some are fun; ...
Anrok reports seven tech trends CFOs must embrace by 2026, including agentic AI, spatial computing, and blockchain, to lead ...
Firm power needs are reshaping Brookfield’s strategy as data center growth pushes utilities and developers toward hydro ...
Presented detailed efficacy and safety results from the PIK3CA wild-type ("WT") cohort of the Phase 3 VIKTORIA-1 clinical trial at a late breaking oral presentation at the 2025 European Society for Me ...
Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results